MONROVIA, Calif., Aug. 5, 2013 /PRNewswire/ -- STAAR Surgical
Company (NASDAQ: STAA), a leading developer, manufacturer and
marketer of implantable lenses for the eye, today announced that it
will participate in the 33rd Annual Canaccord Growth
Conference at the Intercontinental Hotel in Boston. STAAR's presentation will be on
Wednesday, August 14,
2013 at 4:30 p.m.
Eastern Time.
Barry G. Caldwell, President and
CEO, will review the Company's recent financial results and current
business developments. James
Francese, Vice President, Global Marketing, will also be
attending. STAAR will offer a live webcast of its
presentation on the Company's website, www.staar.com, under
Investor Information. An archived replay of the presentation will
be available for 90 days, also at www.staar.com.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for
over 25 years, designs, develops, manufactures and markets
implantable lenses for the eye and delivery systems therefor.
All of these lenses are foldable, which permits the surgeon to
insert them through a small incision. STAAR's lens used in
refractive surgery as an alternative to LASIK is called an
Implantable Collamer® Lens or "ICL." A lens used to replace
the natural lens after cataract surgery is called an intraocular
lens or "IOL." Over 350,000 Visian ICLs have been implanted
to date; to learn more about the ICL go to:
www.visianinfo.com. STAAR has approximately 300 full time
employees and markets lenses in over 60 countries.
Headquartered in Monrovia, CA, it
manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo,
CA; and Monrovia, CA.
For more information, please visit the Company's website at
www.staar.com or call 626-303-7902.
Collamer® is the registered trademark for STAAR's proprietary
biocompatible collagen copolymer lens material.
CONTACT:
Investors
EVC
Group
Douglas Sherk, 415-652-9100
Leigh Salvo, 415-568-9348
Media
EVC Group
Chris Gale
646-201-5431
SOURCE STAAR Surgical Company